| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/16/2010 | WO2010103204A1 Metal ion chelating agents, methods for preparing same and uses thereof |
| 09/16/2010 | WO2010103130A2 Novel bicyclic heterocycles |
| 09/16/2010 | WO2010103120A1 New crystals of a benzoylbenzeneacetamide derivative |
| 09/16/2010 | WO2010103119A1 Compositions and methods for elimination of gram-negative bacteria |
| 09/16/2010 | WO2010103095A1 Tetrahydronaphthalen-2-ol derivatives |
| 09/16/2010 | WO2010103094A1 PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS |
| 09/16/2010 | WO2010103067A1 Pharmaceutical combination of 5-fluorouracil and derivate of 1,4-dihydropyridine and its use in the treatment of cancer |
| 09/16/2010 | WO2010103064A1 Novel benzoxazinone derivatives useful for the treatment of cns disorders |
| 09/16/2010 | WO2010103046A1 N-hydroxy c29-amide derivatives of oleandrane |
| 09/16/2010 | WO2010103040A1 5'-adenosine monophosphate-activated protein kinase (ampk) activators for treating pulmonary hypertension |
| 09/16/2010 | WO2010103039A1 Immediate release pharmaceutical compositions comprising oxycodone and naloxone |
| 09/16/2010 | WO2010103001A1 Tricyclic heterocyclic derivatives |
| 09/16/2010 | WO2010102991A2 Riluzole liquid emulsions |
| 09/16/2010 | WO2010102968A1 Indole derivatives as ikk2 inhibitors |
| 09/16/2010 | WO2010102958A1 4-oxadiazol-2 -yl- indazoles as inhibitors of p13 kinases |
| 09/16/2010 | WO2010102937A1 Covalent milk protein/isothiocyanate complexes |
| 09/16/2010 | WO2010102923A2 Riluzole aqueous suspensions |
| 09/16/2010 | WO2010102862A1 Pharmaceutical formulation comprising ketoprofen and a polyoxyalkylene ester of a hydroxy fatty acid |
| 09/16/2010 | WO2010102831A1 Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenyiethoxy) hexyl]amino}-l- hydroxyethyl)-8-hydroxyquinolin-2(1h)-one. |
| 09/16/2010 | WO2010102826A1 Addition salts of amines containing hydroxyl and/or carboxylic groups with amino nicotinic acid derivatives as dhodh inhibitors |
| 09/16/2010 | WO2010102825A1 Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 09/16/2010 | WO2010102811A1 Substituted 2-mercaptoquinoline-3-carboxamides as kcnq2/3 modulators |
| 09/16/2010 | WO2010102810A1 Substituted 2-mercapto-3-aminopyridines as kcnq2/3 modulators |
| 09/16/2010 | WO2010102809A1 Substituted nicotinamides as kcnq2/3 modulators |
| 09/16/2010 | WO2010102779A1 Substituted 3-amino-2-mercaptoquinolines as kcnq2/3 modulators |
| 09/16/2010 | WO2010102778A2 Substituted 3-aminoisoxazolopyridines as kcnq2/3 modulators |
| 09/16/2010 | WO2010102762A1 Oil-based preparation containing antiprotozoal triazines and anthelmintic cyclodepsipeptides |
| 09/16/2010 | WO2010102737A1 Nanonized testosteron formulations for improved bioavailability |
| 09/16/2010 | WO2010102717A1 Oxo-heterocyclically substituted alkyl carboxylic acids and use thereof |
| 09/16/2010 | WO2010102673A1 Hellebrin and hellebrigenin derivatives |
| 09/16/2010 | WO2010102663A1 Piperazine derivatives for use in therapy |
| 09/16/2010 | WO2010102554A1 New crystalline form vi of agomelatine, preparation method and application thereof |
| 09/16/2010 | WO2010102513A1 Homopiperazine acethydrazide derivatives, preparation method and uses thereof |
| 09/16/2010 | WO2010102512A1 C-aryl glucoside derivatives, preparation process and pharmaceutical use thereof |
| 09/16/2010 | WO2010102508A1 Preparation method of carotenoid oil suspensions with low viscosity and high fluidity and its use |
| 09/16/2010 | WO2010102393A1 2-indolyl imidazo [4,5-d]phenanthroline derivatives and their use to inhibit angiogenesis |
| 09/16/2010 | WO2010088368A3 Imidazopyrazines as protein kinase inhibitors |
| 09/16/2010 | WO2010086881A3 Pharmaceutical compositions comprising phosphate-binding polymer |
| 09/16/2010 | WO2010086617A3 Phosphoantigens for the treatment of burkholderia infections |
| 09/16/2010 | WO2010085665A3 Targeted delivery system |
| 09/16/2010 | WO2010082092A4 Propofol based anesthetic with preservative |
| 09/16/2010 | WO2010081835A3 Bis-resorcinyl-triazine derivatives as protecting agents against uv radiation |
| 09/16/2010 | WO2010080129A3 Extended dicer substrate agents and methods for the specific inhibition of gene expression |
| 09/16/2010 | WO2010077836A3 Pyrrolidine compounds which modulate the cb2 receptor |
| 09/16/2010 | WO2010077669A3 Palonosetron formulation |
| 09/16/2010 | WO2010075204A3 Gamma secretase modulators |
| 09/16/2010 | WO2010075026A3 Methods for determining efficacy of a therapeutic regimen against deleterious effects of cytotoxic agents in human |
| 09/16/2010 | WO2010074936A3 Enzastaurin for the treatment of cancer |
| 09/16/2010 | WO2010070672A3 Phytochemical composition comprising cafeic acid derivatives |
| 09/16/2010 | WO2010068920A3 Diaminoquinazoline inhibitors of dihydrofolate reductase |
| 09/16/2010 | WO2010068520A3 Substituted imidazoheterocycle derivatives |
| 09/16/2010 | WO2010068287A8 Small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 09/16/2010 | WO2010065889A3 Cyclobutanemethanamine inhibitors of monomine reuptake |
| 09/16/2010 | WO2010065865A3 Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| 09/16/2010 | WO2010065329A3 Nanoparticles for cancer treatment |
| 09/16/2010 | WO2010065110A3 Antimicrobials |
| 09/16/2010 | WO2010064261A9 Synergistic combinations of aztreonam with the carbapenems meropenem and ertapenem |
| 09/16/2010 | WO2010062900A3 A new family of pain producing substances and methods to produce novel analgesic drugs |
| 09/16/2010 | WO2010062686A3 Imidazol-4-one and imidazole-4-thione compounds |
| 09/16/2010 | WO2010059913A3 Preparation of rasagiline and salts thereof |
| 09/16/2010 | WO2010059706A3 Translation factors as anti-aging drug targets |
| 09/16/2010 | WO2010059606A3 Inhibitors of diacylglycerol acyltransferase |
| 09/16/2010 | WO2010059241A3 Treatment of amyotrophic lateral sclerosis |
| 09/16/2010 | WO2010057596A3 New therapy and medicament using integrin ligands for treating cancer |
| 09/16/2010 | WO2010057141A3 Alphavirus inhibitors and uses thereof |
| 09/16/2010 | WO2010057118A3 Heterocyclic antagonists of prostaglandin d2 receptors |
| 09/16/2010 | WO2010057006A9 Azaquinolinone derivatives and uses thereof |
| 09/16/2010 | WO2010056910A3 Methods of treating cardiovascular disorders |
| 09/16/2010 | WO2010056847A3 Lyophilization formulation |
| 09/16/2010 | WO2010056737A3 Methods and compositions involving mirnas in cancer stem cells |
| 09/16/2010 | WO2010056672A3 Butylammonium modulators of fatty acid transport |
| 09/16/2010 | WO2010056320A3 Pi3k/mtor kinase inhibitors |
| 09/16/2010 | WO2010054286A3 Substituted hydroxyphenylamine compounds |
| 09/16/2010 | WO2010054285A3 Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors |
| 09/16/2010 | WO2010054056A3 Nilotinib hci crystalline forms |
| 09/16/2010 | WO2010053583A3 Small molecule cd4 mimetics and uses thereof |
| 09/16/2010 | WO2010048526A3 Modulators of cystic fibrosis transmembrane conductance regulator |
| 09/16/2010 | WO2010048228A3 Compositions and methods for inhibiting expression of transthyretin |
| 09/16/2010 | WO2010042212A3 Methods for treating or preventing pain using spicamycin derivatives |
| 09/16/2010 | WO2010041268A3 Crosslinked polymers |
| 09/16/2010 | WO2010039237A8 Compounds for inflammation and immune-related uses |
| 09/16/2010 | WO2010014921A3 A3 adenosine receptor antagonists and partial agonists |
| 09/16/2010 | WO2009147144A3 Composition comprising an antibiotic and a corticosteroid |
| 09/16/2010 | WO2009103807A8 Copper organocomplexes, use thereof as antitumor means and for protecting healthy tissue from ionizing radiation |
| 09/16/2010 | WO2009087238A3 Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies |
| 09/16/2010 | WO2006135734A3 Compositions and methods for altering bone density and bone patterning |
| 09/16/2010 | WO2006113246A3 Small activating rna molecules and methods of use |
| 09/16/2010 | US20100235936 Zinc-finger nuclease and rna interference mediated inactivation of viral genomes |
| 09/16/2010 | US20100235935 Plasma anti-diabetic nucb2 peptide (pladin) and uses thereof |
| 09/16/2010 | US20100235933 Kaspp (lrrk2) gene, its production and use for the detection and treatment of neurodegenerative disorders |
| 09/16/2010 | US20100235931 Novel Neurological Function of mPKCI |
| 09/16/2010 | US20100234828 Methods and Compositions for Facilitating Arterial Access |
| 09/16/2010 | US20100234784 Interpenetrating network of pva hydrogel cool-compression bandage |
| 09/16/2010 | US20100234766 Topical administration of a salt compound to facilitate venipuncture |
| 09/16/2010 | US20100234599 Method for preparing acid addition salts of polyacidic basic compounds |
| 09/16/2010 | US20100234591 Biaryl heterocyclic compounds and methods of making and using the same |
| 09/16/2010 | US20100234474 Method and Composition for Evenly Applying Water Soluble Actives |
| 09/16/2010 | US20100234473 Process for preparation of 3-(2-hydroxy-5-substituted phenyl)-n-alkyl-3-phenylpropylamines |
| 09/16/2010 | US20100234472 Nitric oxide releasing derivatives of paracetamol |
| 09/16/2010 | US20100234471 Lidocaine tape preparation |